⌘K

Login Start Free

Home/Filings/4/0001209191-17-050554

4//SEC Filing

Brzeczko Albert W 4

Accession 0001209191-17-050554

CIK 0000786947other

View on SEC.gov Company Profile

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 4:12 PM ET

Size

15.3 KB

Accession

0001209191-17-050554

Insider Transaction Report

Form 4

Period: 2017-08-25

ACURA PHARMACEUTICALS, INCACUR

Brzeczko Albert W

VP Technical Affairs

Transactions

Purchase
Common Stock
2017-08-25$0.48/sh+1,000$480→ 7,200 total
Purchase
Common Stock
2017-08-25$0.48/sh+1,800$864→ 10,000 total
Purchase
Common Stock
2017-08-29$0.47/sh+1,000$470→ 16,000 total
Purchase
Common Stock
2017-08-29$0.47/sh+2,000$940→ 14,000 total
Purchase
Common Stock
2017-08-25$0.48/sh+1,000$480→ 6,200 total
Purchase
Common Stock
2017-08-28$0.45/sh+2,000$909→ 12,000 total
Purchase
Common Stock
2017-08-25$0.48/sh+1,000$480→ 8,200 total
Purchase
Common Stock
2017-08-29$0.47/sh+1,000$470→ 15,000 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ACURA PHARMACEUTICALS, INC

CIK 0000786947

Entity typeother

Related Parties

1

filerCIK 0001455740

Filing Metadata

Form type: 4
Filed: Aug 28, 8:00 PM ET
Accepted: Aug 29, 4:12 PM ET
Size: 15.3 KB

View on SEC.gov